Thoracic ultrasound in guiding management of respiratory disease.

Ultrasound lung cancer lymph node biopsy pleural biopsy pleural effusion pneumonia pneumothorax pulmonary embolism respiratory disease

Journal

Expert review of respiratory medicine
ISSN: 1747-6356
Titre abrégé: Expert Rev Respir Med
Pays: England
ID NLM: 101278196

Informations de publication

Date de publication:
03 Aug 2024
Historique:
medline: 4 8 2024
pubmed: 4 8 2024
entrez: 3 8 2024
Statut: aheadofprint

Résumé

Theuse of ultrasound in respiratory disease has evolved substantially over thepast two decades. From a test done to confirm the safe site of pleural fluiddrainage, thoracic ultrasound has become a point-of-care test that guides themanagement of patients on respiratory wards, in clinics and endoscopy. This review overviews of process ofultrasound examination in the chest. It then delves into specific disease areas(pleural disease, lung disease, diaphragm disease, and invasive procedures) tohighlight how thoracic ultrasound is being used to refine management. Thereview concludes with discussion on the training curricula and assessment toolsfor competency in thoracic ultrasound. Being a scoping review, literaturesearches were conducted on PubMed using relevant search terms. Inaddition to its current uses, there are many avenues where thoracic ultrasound willsoon be beneficial. Recent studies show promising roles in areas such aspatient-tailored guidance of pleurodesis and non-invasively predicting lungre-expansion after pleural fluid drainage. In addition, auxiliary tools such ascontrast-enhanced ultrasound and elastography are proving useful in identifyingthe etiology and directing the successful sample of pleural and lung lesions. Studiesare also exploring the utility of sonographic biomarkers such as echogenicity andseptations to predict outcomes in pleural disease.

Identifiants

pubmed: 39096207
doi: 10.1080/17476348.2024.2387785
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Maged Hassan (M)

Chest Diseases Department, Alexandria University Medicine, Alexandria, Egypt.

Sally Griffiths (S)

Interventional Respiratory Unit, Department of Respiratory Medicine, Galway University Hospitals, Galway, Ireland.

Ben Probyn (B)

Department of Respiratory Medicine, University Hospitals Plymouth NHS Trust, Plymouth, UK.

Ahmed S Sadaka (AS)

Chest Diseases Department, Alexandria University Medicine, Alexandria, Egypt.

Abdelfattah A Touman (AA)

Pulmonary Medicine Department, King Abdullah Medical City, Makkah, Saudi Arabia.

Gareth Trevelyan (G)

Department of Respiratory Medicine, University Hospitals Plymouth NHS Trust, Plymouth, UK.

David Breen (D)

Interventional Respiratory Unit, Department of Respiratory Medicine, Galway University Hospitals, Galway, Ireland.

Cyrus Daneshvar (C)

Department of Respiratory Medicine, University Hospitals Plymouth NHS Trust, Plymouth, UK.
Plymouth Medical School, Faculty of Health, University of Plymouth, Plymouth, UK.

Classifications MeSH